Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of WEE1 Inhibition with Chemotherapy and Radiotherapy As Adjuvant Treatment, and a Window of Opportunity Trial with Cisplatin in Patients with Head and Neck Cancer

NCT03028766 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT03028766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03028766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of WEE1 Inhibition with Chemotherapy and Radiotherapy As Adjuvant Treatment, and a Window of Opportunity Trial with Cisplatin in Patients with Head and Neck Cancer
Lead sponsor
University of Birmingham
Phase
Phase 1
Overall status
Completed
Start date
June 22, 2017
Completion date
February 3, 2021
Enrollment
9 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hypopharynx squamous cell carcinoma, larynx cancer, oral cavity squamous cell carcinoma